TITLE

Value of124I-PET/CT in staging of patients with differentiated thyroid cancer

AUTHOR(S)
Freudenberg, L.; Antoch, G.; Jentzen, W.; Pink, R.; Knust, J.; Görges, R.; Müller, S.; Bockisch, A.; Debatin, J.; Brandau, W.
PUB. DATE
November 2004
SOURCE
European Radiology;Nov2004, Vol. 14 Issue 11, p2092
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The aim of this study is to evaluate the clinical significance of124I positron emission tomography (PET) using a combined PET/CT tomograph in patients with differentiated thyroid carcinoma and to compare the PET/CT results with131I whole-body scintigraphy (WBS), dedicated PET and CT alone. Twelve thyroid cancer patients were referred for diagnostic workup and entered complete clinical evaluation, including histology, cytology, thyroglobulin level, ultrasonography, fluorine-18 fluorodeoxyglucose (FDG)-PET, FDG-PET/CT and CT. Lesion-based evaluation showed a lesion delectability of 56, 87 and 100% for CT,124I-PET, and combined124I-PET/CT imaging, respectively. Lesion delectability of131I-WBS was 83%. We conclude that124I-PET/CT imaging is a promising technique to improve treatment planning in thyroid cancer. It is particularly valuable in patients suffering from advanced differentiated thyroid cancer prior to radio-iodine therapy and in patients with suspected recurrence and potential metastatic disease.
ACCESSION #
15399438

 

Related Articles

  • Comparison of whole-body [sup 18]F-FDG PET, [sup 99m]Tc-MIBI SPET, and post-therapeutic [sup 131]I-Na scintigraphy in the detection of metastatic thyroid cancer. Iwata, Masahiro; Kasagi, Kanji; Misaki, Takashi; Matsumoto, Keiichi; Iida, Yasuhiro; Ishimori, Takayoshi; Nakamoto, Yuji; Higashi, Tatsuya; Saga, Tsuneo; Konishi, Junji // European Journal of Nuclear Medicine & Molecular Imaging;2004, Vol. 31 Issue 4, p491 

    The usefulness of fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in differentiated thyroid cancer (DTC) has been demonstrated by many investigators, but in only a small number of studies have FDG-PET images been compared with those obtained using other non-iodine...

  • Influence of TSH on uptake of [[sup 18]F]fluorodeoxyglucose in human thyroid cells in vitro. Deichen, J.T.; Schmidt, C.; Prante, O.; Maschauer, S.; Papadopoulos, T.; Kuwert, T. // European Journal of Nuclear Medicine & Molecular Imaging;2004, Vol. 31 Issue 4, p507 

    Recent clinical evidence suggests that positron emission tomography with fluorine-18 fluorodeoxyglucose (FDG-PET) is more accurate in detecting thyroid carcinomatous tissue at high than at low TSH levels. The aim of this study was to determine the influence of TSH on FDG uptake in human thyroid...

  • FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Kubota, Kazuo; Yokoyama, Jyunkichi; Yamaguchi, Keiichiro; Ono, Shuichi; Qureshy, Ahmad; Itoh, Masatoshi; Fukuda, Hiroshi // European Journal of Nuclear Medicine & Molecular Imaging;2004, Vol. 31 Issue 4, p590 

    In advanced head and neck cancer, an organ-sparing approach comprising radiation therapy combined with intra-arterial chemotherapy has become an important technique. However, the high incidence of residual masses after therapy remains a problem. In this study, we prospectively evaluated the use...

  • Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma. Wong, K. K.; Zarzhevsky, N.; Cahill, J. M.; Frey, K. A.; Avram, A. M. // British Journal of Radiology;Oct2009, Vol. 82 Issue 982, p860 

    Hybrid imaging modalities such as radioiodine single photon emission CT with integrated CT (131I SPECT-CT) and 2-(fluorine-18)-fluoro-2-deoxy-D-glucose positron emission tomography with integrated CT (FDG PET-CT) allow the rapid and efficient fusion of functional and anatomic images, and provide...

  • Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement. Urhan, Muammer; Dadparvar, Simin; Mavi, Ayse; Houseni, Mohamed; Chamroonrat, Wichana; Alavi, Abass; Mandel, Susan // European Journal of Nuclear Medicine & Molecular Imaging;Jul2007, Vol. 34 Issue 7, p1012 

    Using 123I for diagnostic purposes avoids the risk of stunning for subsequent radioiodine treatment and affords an excellent image quality. In this study we assessed the role of 123I in comparison with 131I post-treatment imaging in patients with thyroid cancer. We compared a total of 292 123I...

  • Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3- O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma. Beuthien-Baumann, B.; Strumpf, A.; Zessin, J.; Bredow, J.; Kotzerke, J. // European Journal of Nuclear Medicine & Molecular Imaging;Oct2007, Vol. 34 Issue 10, p1604 

    In patients with medullary thyroid carcinoma (MTC), rising levels of the tumour markers calcitonin and CEA after primary surgery indicate tumour recurrence or metastases. The only chance of cure is the resection of localised tumour tissue. For positron emission tomography (PET) with...

  • Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems. Jentzen, Walter; Weise, Reiner; Kupferschläger, Jürgen; Freudenberg, Lutz; Brandau, Wolfgang; Bares, Ronald; Burchert, Wolfgang; Bockisch, Andreas // European Journal of Nuclear Medicine & Molecular Imaging;Mar2008, Vol. 35 Issue 3, p611 

    This study evaluated the absolute quantification of iodine-124 (124I) activity concentration with respect to the use of this isotope for dosimetry before therapies with 131I or 131I-labeled radiotherapeuticals. The recovery coefficients of positron emission tomography(/computed tomography)...

  • Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Çermik, Tevfik F.; Mavi, Ayse; Basu, Sandip; Alavi, Abass // European Journal of Nuclear Medicine & Molecular Imaging;Mar2008, Vol. 35 Issue 3, p475 

    The main objective of this study was to determine the efficacy of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) to assess the impact of this technique in staging of patients with newly diagnosed breast cancer. Two hundred and seventy-one consecutive patients (median age = 51 ±...

  • The incremental value of dual modality PET/CT imaging over PET imaging alone in advanced colorectal cancer. Engledow, A. H.; Bond-Smith, G. E. L.; Francis, D.; Pakzad, F.; Bomanji, J.; Groves, A.; Ell, P. J. // Indian Journal of Surgery;Apr2009, Vol. 71 Issue 2, p63 

    18Fluoro-2-Deoxy Glucose (18 FDG) positron emission tomography (PET) impacts upon the management of recurrent colorectal cancer (CRC) but is limited by anatomical localisation. The development of integrated positron emission and computerised tomography (PET/CT) yields high anatomical resolution...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics